Financhill
Sell
23

PLAG Quote, Financials, Valuation and Earnings

Last price:
$2.23
Seasonality move :
44.73%
Day range:
$2.20 - $2.39
52-week range:
$0.39 - $5.80
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
7.88x
P/B ratio:
8.65x
Volume:
12.6K
Avg. volume:
276.7K
1-year change:
459.44%
Market cap:
$158.6M
Revenue:
$27.1M
EPS (TTM):
-$0.29
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $1.1M $3.6M $37.8M $44.8M $27.1M
Revenue Growth (YoY) -83.8% 228.86% 937.92% 18.51% -39.41%
 
Cost of Revenues $464.4K $2.4M $33.9M $40.4M $25.7M
Gross Profit $642.1K $1.3M $3.8M $4.4M $1.4M
Gross Profit Margin 58.03% 34.88% 10.18% 9.72% 5.28%
 
R&D Expenses -- -- $808.4K $402.7K $269.5K
Selling, General & Admin $945K $4.1M $9.3M $9.2M $9.9M
Other Inc / (Exp) $8.9M -$8.4M -$3.1M -$9.4M -$11.5M
Operating Expenses $945K $4.1M $10.1M $9.6M $10.2M
Operating Income -$302.9K -$2.8M -$6.2M -$5.3M -$8.8M
 
Net Interest Expenses $9.7K $23.4K $645.1K $624.4K $496.1K
EBT. Incl. Unusual Items $8.5M -$11.2M -$9.9M -$15.3M -$20.8M
Earnings of Discontinued Ops. -$5.6M $150.9K -- -$9.2M --
Income Tax Expense -- -- $56.5K $1.5M $35.3K
Net Income to Company $8.5M -$11.1M -$10M -$25.8M -$20.8M
 
Minority Interest in Earnings -- -- $250.6K $126.5K --
Net Income to Common Excl Extra Items $2.9M -$11.1M -$9.7M -$25.8M -$20.8M
 
Basic EPS (Cont. Ops) $0.43 -$1.09 -$0.39 -$0.43 -$0.29
Diluted EPS (Cont. Ops) $0.43 -$1.09 -$0.39 -$0.43 -$0.29
Weighted Average Basic Share $6.9M $10.1M $24.8M $59.5M $72.1M
Weighted Average Diluted Share $6.9M $10.1M $24.8M $59.5M $72.1M
 
EBITDA -$88.9K -$10.7M -$6.8M -$13.2M -$18.1M
EBIT -$302.9K -$11.2M -$9.3M -$14.6M -$20.3M
 
Revenue (Reported) $1.1M $3.6M $37.8M $44.8M $27.1M
Operating Income (Reported) -$302.9K -$2.8M -$6.2M -$5.3M -$8.8M
Operating Income (Adjusted) -$302.9K -$11.2M -$9.3M -$14.6M -$20.3M
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Revenue $834.7K $2.2M $12M $8.5M $1.5M
Revenue Growth (YoY) -22.59% 167.89% 435.72% -28.76% -82.06%
 
Cost of Revenues $852.1K $2M $10.8M $8.3M $1.2M
Gross Profit -$17.4K $205.6K $1.2M $246.4K $362.8K
Gross Profit Margin -2.08% 9.19% 9.71% 2.89% 23.7%
 
R&D Expenses -- -- $8.9K $68.7K $45.7K
Selling, General & Admin $430.4K $1.8M $2.3M $1.3M $1.2M
Other Inc / (Exp) -$142.9K $199.4K $85.2K $38.3K $3K
Operating Expenses $430.4K $1.8M $2.3M $1.4M $1.3M
Operating Income -$447.8K -$1.6M -$1.1M -$1.2M -$927.1K
 
Net Interest Expenses -- $109.5K $157.2K $116.1K $122.8K
EBT. Incl. Unusual Items -$589.8K -$1.5M -$1.2M -$1.2M -$1M
Earnings of Discontinued Ops. -- -- -- -- -$34K
Income Tax Expense -- -- $89.4K $47.6K --
Net Income to Company -$589.8K -$1.5M -$1.3M -$1.3M -$1M
 
Minority Interest in Earnings -- $102.9K $31.7K -- --
Net Income to Common Excl Extra Items -$589.8K -$1.4M -$1.2M -$1.3M -$1.1M
 
Basic EPS (Cont. Ops) -$0.07 -$0.08 -$0.03 -$0.02 -$0.01
Diluted EPS (Cont. Ops) -$0.07 -$0.08 -$0.03 -$0.02 -$0.01
Weighted Average Basic Share $8M $16.7M $41.6M $72.1M $72.1M
Weighted Average Diluted Share $8M $16.7M $41.6M $72.1M $72.1M
 
EBITDA -$281K -$818.8K -$259.1K -$543.2K -$406.9K
EBIT -$447.8K -$1.4M -$1M -$1.1M -$923.9K
 
Revenue (Reported) $834.7K $2.2M $12M $8.5M $1.5M
Operating Income (Reported) -$447.8K -$1.6M -$1.1M -$1.2M -$927.1K
Operating Income (Adjusted) -$447.8K -$1.4M -$1M -$1.1M -$923.9K
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Revenue $2.7M $5.1M $47.5M $41.3M $20.1M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $2.1M $3.6M $42.7M $37.9M $18.6M
Gross Profit $690.3K $1.5M $4.8M $3.4M $1.5M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- $817.3K $462.5K $246.5K
Selling, General & Admin $1.5M $5.6M $9.7M $8.3M $9.8M
Other Inc / (Exp) $8.7M -$8M -$3.2M -$9.4M -$11.6M
Operating Expenses $1.5M $5.6M $10.6M $8.8M $10.1M
Operating Income -$815.7K -$4.1M -$5.8M -$5.3M -$8.5M
 
Net Interest Expenses $8.9K $138.2K $692.8K $583.3K $502.8K
EBT. Incl. Unusual Items $7.9M -$12.3M -$9.6M -$15.3M -$20.6M
Earnings of Discontinued Ops. -$5.5M $301.8K -- -- -$33.9K
Income Tax Expense -- -- $145.9K $1.4M -$12.3K
Net Income to Company $7.9M -$12M -$9.8M -$25.8M -$20.6M
 
Minority Interest in Earnings -- $102.9K $179.4K $94.9K --
Net Income to Common Excl Extra Items $2.3M -$11.8M -$9.6M -$25.9M -$20.6M
 
Basic EPS (Cont. Ops) $0.45 -$0.29 -$0.34 -$0.42 -$0.29
Diluted EPS (Cont. Ops) $0.45 -$0.29 -$0.34 -$0.42 -$0.29
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -$250.3K -$11.4M -$6.3M -$13.4M -$18M
EBIT -$846.6K -$12.3M -$8.9M -$14.7M -$20.1M
 
Revenue (Reported) $2.7M $5.1M $47.5M $41.3M $20.1M
Operating Income (Reported) -$815.7K -$4.1M -$5.8M -$5.3M -$8.5M
Operating Income (Adjusted) -$846.6K -$12.3M -$8.9M -$14.7M -$20.1M
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Revenue $834.7K $2.2M $12M $8.5M $1.5M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $852.1K $2M $10.8M $8.3M $1.2M
Gross Profit -$17.4K $205.6K $1.2M $246.4K $362.8K
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- $8.9K $68.7K $45.7K
Selling, General & Admin $430.4K $1.8M $2.3M $1.3M $1.2M
Other Inc / (Exp) -$142.9K $199.4K $85.2K $38.3K $3K
Operating Expenses $430.4K $1.8M $2.3M $1.4M $1.3M
Operating Income -$447.8K -$1.6M -$1.1M -$1.2M -$927.1K
 
Net Interest Expenses -- $109.5K $157.2K $116.1K $122.8K
EBT. Incl. Unusual Items -$589.8K -$1.5M -$1.2M -$1.2M -$1M
Earnings of Discontinued Ops. -- -- -- -- -$34K
Income Tax Expense -- -- $89.4K $47.6K --
Net Income to Company -$589.8K -$1.5M -$1.3M -$1.3M -$1M
 
Minority Interest in Earnings -- $102.9K $31.7K -- --
Net Income to Common Excl Extra Items -$589.8K -$1.4M -$1.2M -$1.3M -$1.1M
 
Basic EPS (Cont. Ops) -$0.07 -$0.08 -$0.03 -$0.02 -$0.01
Diluted EPS (Cont. Ops) -$0.07 -$0.08 -$0.03 -$0.02 -$0.01
Weighted Average Basic Share $8M $16.7M $41.6M $72.1M $72.1M
Weighted Average Diluted Share $8M $16.7M $41.6M $72.1M $72.1M
 
EBITDA -$281K -$818.8K -$259.1K -$543.2K -$406.9K
EBIT -$447.8K -$1.4M -$1M -$1.1M -$923.9K
 
Revenue (Reported) $834.7K $2.2M $12M $8.5M $1.5M
Operating Income (Reported) -$447.8K -$1.6M -$1.1M -$1.2M -$927.1K
Operating Income (Adjusted) -$447.8K -$1.4M -$1M -$1.1M -$923.9K
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $7.3M $3.4M $750.7K $93.5K $436.4K
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $66.7K $835.4K $3.8M $3M $3.2M
Inventory $1.9M $2.3M $7.8M $4.2M $2M
Prepaid Expenses $1.6M $5.9M $5.7M $6M $6.3M
Other Current Assets -- -- -- -- --
Total Current Assets $18.2M $13.5M $27.3M $13.8M $12.5M
 
Property Plant And Equipment $4.2M $4.6M $23.5M $22.6M $20.3M
Long-Term Investments -- -- $3.8M $16.5M $2.3M
Goodwill -- $2.3M $18.2M $4.7M $4.7M
Other Intangibles $1.5M $1.5M $4.2M $3.1M $2.8M
Other Long-Term Assets $2.1M -- -- -- --
Total Assets $25.9M $22M $86M $60.7M $42.6M
 
Accounts Payable $765.4K $1.3M $6.2M $3.5M $3.6M
Accrued Expenses $1.5M -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- $436.2K -- --
Other Current Liabilities $376.7K -- -- -- --
Total Current Liabilities $4.8M $3.6M $34.4M $19.6M $19.2M
 
Long-Term Debt -- -- $380.4K $287.2K $3.8M
Capital Leases -- -- -- -- --
Total Liabilities $5.2M $3.7M $34.8M $20.1M $23.2M
 
Common Stock $7.9K $11.8K $35.6K $72.1K $72.1K
Other Common Equity Adj $8.2M $7M $7.7M $4.7M $4.4M
Common Equity $20.7M $18.3M $46.9M $40.6M $19.4M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- $4.3M -- --
Total Equity $20.7M $18.3M $51.3M $40.6M $19.4M
 
Total Liabilities and Equity $25.9M $22M $86M $60.7M $42.6M
Cash and Short Terms $7.3M $3.4M $750.7K $93.5K $436.4K
Total Debt -- -- $7.2M $3.9M $3.8M
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Cash and Equivalents $4.1M $1.5M $354.3K $224.2K $403.1K
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $1.8M $1.7M $3.3M $3.6M $3M
Inventory $2.3M $3.5M $8M $4M $2.2M
Prepaid Expenses $10.5M $7.2M $6.4M $6.9M $5M
Other Current Assets -- -- -- -- --
Total Current Assets $19M $20.9M $27.9M $15.4M $13.4M
 
Property Plant And Equipment $5.9M $20.1M $23M $22.4M $19.8M
Long-Term Investments -- -- $5.9M $16.5M $2.3M
Goodwill -- $6.5M $18.2M $4.7M $4.7M
Other Intangibles $1.5M $3.6M $4.2M $3.1M $2.8M
Other Long-Term Assets $313K -- -- -- --
Total Assets $26.7M $52.1M $88.1M $62.1M $42.9M
 
Accounts Payable $1M $1.8M $6.3M $3.8M $3.2M
Accrued Expenses $1.5M $4.4M -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $24.8K $408.7K $443.2K -- --
Other Current Liabilities -- -- -- -- $537K
Total Current Liabilities $3M $13.2M $35.9M $21.9M $20.6M
 
Long-Term Debt -- -- -- $291.1K $3.8M
Capital Leases -- -- -- -- --
Total Liabilities $3.4M $14M $36.2M $22.5M $24.6M
 
Common Stock $9.2K $20K $42.6K $72.1K $72.1K
Other Common Equity Adj $7.9M $6.5M $7.9M $5M $4.4M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- $2.1M $2M -- --
Total Equity $23.3M $38.2M $51.9M $39.6M $18.3M
 
Total Liabilities and Equity $26.7M $52.1M $88.1M $62.1M $42.9M
Cash and Short Terms $4.1M $1.5M $354.3K $224.2K $403.1K
Total Debt $203.9K $4.3M $6.7M $3.9M $5.2M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $8.5M -$11.1M -$10M -$25.8M -$20.8M
Depreciation & Amoritzation $214.1K $449.1K $2.5M $1.5M $2.2M
Stock-Based Compensation -- $1.8M $1.2M -- --
Change in Accounts Receivable $58.1K -$1.5M -$4.8M -$526K -$1.9M
Change in Inventories -$434.4K -$296K -$1.3M -- $2.1M
Cash From Operations -$5.4M -$3.5M -$519.4K -$9M -$5.3M
 
Capital Expenditures $578.6K $852.8K $1.5M -- $97.6K
Cash Acquisitions -- -- $482.8K $246.3K $2.8M
Cash From Investing -$516.3K -$852.8K -$11.8M -$3.9M $2.7M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- $3M --
Long-Term Debt Repaid -$1.1M -- -$2M -$3.2M -$78.9K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities $2M -$2.8M -- -- $3M
Cash From Financing $13.2M $238.4K $8.9M $10.8M $2.9M
 
Beginning Cash (CF) $16.9K $7.3M $3.4M $1.1M $93.5K
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $7.3M -$4.1M -$3.4M -$2M $276.2K
Ending Cash (CF) $7.3M $3.4M $1.1M $93.5K $436.4K
 
Levered Free Cash Flow -$6M -$4.4M -$2M -$9M -$5.4M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$8.2M -$2.4M -$2.3M -$1.3M --
Depreciation & Amoritzation $121.5K $631.5K $179K $573.7K --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$2.4M $5.1M $1.1M $175.2K --
Change in Inventories -$277.7K -$4.1M $67.7K -$1.4M --
Cash From Operations $1.1M -$4.3M -$2M -$2M --
 
Capital Expenditures $74.9K -$268.4K -- $50.1K --
Cash Acquisitions -- -- -- $2.8M --
Cash From Investing -$83.8K $7.5M $582.4K -$50.1K --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $35.3K -- -- -- --
Long-Term Debt Repaid -- -- -$103.4K -$19.5K --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities $102.7K -$1.2K $1M $1.5M --
Cash From Financing $141.9K -$3.9M $928.2K $1.5M --
 
Beginning Cash (CF) $4.2M $1.4M $378.7K $713.2K --
Foreign Exchange Rate Adjustment $164.2K $47.2K $429.5K $157.1K --
Additions / Reductions $1.2M -$737.8K -$497.1K -$556.8K --
Ending Cash (CF) $5.6M $755K $311.1K $313.5K --
 
Levered Free Cash Flow $1.1M -$4M -$2M -$2.1M --
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Net Income to Stockholders $7.9M -$12M -$9.8M -$25.8M -$20.6M
Depreciation & Amoritzation $271.3K $845.2K $2.6M $1.3M $2.2M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$1M -$4.6M -$727.1K -$1.4M -$1.3M
Change in Inventories -$785.5K -$237.7K -$1.3M $478.5K $1.6M
Cash From Operations -$12.2M -$6.7M $3.8M -$3.2M -$5.6M
 
Capital Expenditures $866.2K $733.9K $1.5M -$124.8K $74.3K
Cash Acquisitions -- -- $482.8K $246.3K $2.8M
Cash From Investing -$803.9K -$733.9K -$11.8M -$3.7M $2.7M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -$2.1M -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -$1.1M -$3M $1.1M $1.6M
Cash From Financing $16.7M $5.1M $6.1M $5.1M $2.9M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $3.7M -$2.3M -$1.9M -$1.9M $9.3K
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$13M -$7.5M $2.3M -$3.1M -$5.6M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$8.9M -$5.1M -$5.1M -$14.8M -$1M
Depreciation & Amoritzation $369.2K $1.7M $1.2M $1.7M $517K
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$4M $1.8M $2.2M $182.6K $96.1K
Change in Inventories -$474.1K -$4.4M -$421K -$1.1M -$273.8K
Cash From Operations -$5.1M -$13.1M -$10.2M -$4.2M $183.6K
 
Capital Expenditures $407.3K $42.3K -- $70.9K --
Cash Acquisitions -- -- $246.3K $2.8M --
Cash From Investing -$416.2K -$42.4K -$3.3M $2.7M $11.5K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $147.5K -- -- -- $1.4M
Long-Term Debt Repaid -- -- -$677.6K -$59K --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- $141.5K $892.1K $1.6M -$1.6M
Cash From Financing $3.7M $10M $11.3M $1.5M -$225.7K
 
Beginning Cash (CF) $15.8M $6.3M $2.8M $1M $436.4K
Foreign Exchange Rate Adjustment $89K $575.7K $1.3M $233.9K -$2.7K
Additions / Reductions -$1.9M -$3.2M -$2.2M -$13.9K -$30.7K
Ending Cash (CF) $14M $3.7M $2M $1.3M $403.1K
 
Levered Free Cash Flow -$5.6M -$13.2M -$10.2M -$4.3M $183.6K

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock